Several other mechanisms have been described for ApoE4 in relation to AD, including neuronal hyperactivation [25], increased Tau phosphorylation [26], modulation of neuroinflammatory pathways [23], and impaired synaptic plasticity [27]. The gene discussed is MAPT; the disease is Alzheimer disease.